PCM
ZLTQ

Prelude Capital Management’s ZELTIQ Aesthetics, Inc. ZLTQ Stock Holding History

Prelude Capital Management’s Portfolio ZLTQ Stock Details ZLTQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-64,243
Closed -$3.57M – 2052
2017
Q1 		$3.57M Buy
64,243
+63,046
+5,267% +$3.16M 0.34% 54
2016
Q4 		$52K Buy
+1,197
New +$48.3K 0.01% 1037
2016
Q1 		– Sell
-10,780
Closed -$308K – 1721
2015
Q4 		$308K Hold
10,780
– – 0.05% 402
2015
Q3 		$345K Sell
10,780
-7,081
-40% -$235K 0.05% 385
2015
Q2 		$526K Buy
17,861
+5,281
+42% +$159K 0.07% 296
2015
Q1 		$388K Buy
12,580
+10,780
+599% +$345K 0.05% 417
2014
Q4 		$50K Hold
1,800
– – 0.01% 1242
2014
Q3 		$41K Buy
+1,800
New +$35.6K 0.01% 1453
2014
Q2 		– Sell
-8,000
Closed -$157K – 2332
2014
Q1 		$157K Buy
8,000
+2,300
+40% +$44.9K 0.02% 821
2013
Q4 		$108K Sell
5,700
-600
-10% -$8.57K 0.02% 833
2013
Q3 		$57K Buy
+6,300
New +$46.8K 0.01% 914

Other funds holding ZLTQ

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Prelude Capital Management's ZLTQ Position: Q2 2017 in Review

Prelude Capital Management sold out of ZELTIQ Aesthetics, Inc. (ZLTQ) in Q2 2017, closing a stake of 64,243 shares — an estimated $3.57M sold.

Prelude Capital Management first reported a position in ZLTQ in Q3 2013 and held it in 11 quarters. The position peaked at $3.57M in Q1 2017. 2 funds tracked by Wall St. Rank hold ZLTQ as of Q2 2017.

  • Prelude Capital Management reported no remaining ZELTIQ Aesthetics, Inc. position as of Q2 2017 after selling out during the quarter.
  • Prelude Capital Management sold 64,243 ZELTIQ Aesthetics, Inc. shares in Q2 2017, an estimated $3.57M.
  • Prelude Capital Management first reported a position in ZELTIQ Aesthetics, Inc. in Q3 2013 and held it in 11 quarters.
  • Prelude Capital Management's ZELTIQ Aesthetics, Inc. position peaked at $3.57M in Q1 2017.
  • 2 funds tracked by Wall St. Rank held ZELTIQ Aesthetics, Inc. as of Q2 2017.

Based on Prelude Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.